SCHEMBL7246261

SCHEMBL7246261

COc1cc(C(=O)N2CCCCc3cc(Cl)ccc32)ccc1OC(C)=O

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AVPR2 P30518 6/20 0.59
PDE4A P27815 1/20 0.59
PDE4B Q07343 1/20 0.59
PDE4C Q08493 1/20 0.59
PDE4D Q08499 1/20 0.59
HDAC1 Q13547 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
NR3C1 P04150 2/20 0.51
TP53 P04637 2/20 0.51
AVPR1A P37288 1/20 0.50
MAPT P10636 2/20 0.49
LMNA P02545 1/20 0.48
PDE3B Q13370 1/20 0.48
PDE3A Q14432 1/20 0.48
IDO1 P14902 1/20 0.47
KCNH2 Q12809 1/20 0.47
SPTLC2 O15270 1/20 0.47
NOTUM Q6P988 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7245141 0.86 AVPR2 (0.62) AVPR2PDE4APDE4BPDE4CPDE4D
SCHEMBL7022992 0.85 AVPR2 (0.61) AVPR2PDE4APDE4BPDE4CPDE4D
SCHEMBL7024124 0.84 AVPR2 (0.60) AVPR2PDE4APDE4BPDE4CPDE4D
SCHEMBL7027005 0.84 AVPR2 (0.59) AVPR2PDE4APDE4BPDE4CPDE4D
SCHEMBL7238694 0.81 PDE4A (0.56) AVPR2PDE4APDE4BPDE4CPDE4D
SCHEMBL7017018 0.80 AVPR2 (0.54) AVPR2PDE4APDE4BPDE4CPDE4D
SCHEMBL14307268 0.77 PDE4A (0.74) PDE4APDE4BPDE4CPDE4DNR3C1
SCHEMBL13317243 0.75 PDE4A (0.61) AVPR2PDE4APDE4BPDE4CPDE4D
SCHEMBL3623469 0.75 PDE4A (0.61) PDE4APDE4BPDE4CPDE4DNR3C1
SCHEMBL29941834 0.74 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6642223-B2 A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2003-11-04 US claimed